AgAnt: A computational tool to assess Agonist/Antagonist mode of interaction
Abstract
Activity modulation of proteins is an essential biochemical process in cell. The interplay of the protein, as receptor, and its corresponding ligand dictates the functional effect. An agonist molecule when bound to a receptor produces a response within the cell while an antagonist will block the binding site/produce the opposite effect of that of an agonist. Complexity grows with scenarios where some ligands might act as an agonist in certain conditions while as an antagonist in others [1, 3]. It is imperative to decipher the receptor-ligand functional effect for understanding native biochemical processes as well as for drug discovery. Experimental activity determination is a time extensive process and computational solution towards prediction of activity specific to the receptor-ligand interaction would be of wide interest.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combined docking and machine learning identifies key molecular determinants of ligand pharmacological activity on β2 adrenoceptor.
Mireia Jiménez‐Rosés, Bradley Angus Morgan, … Dmitry B. Veprintsev·Pharmacology Research & PerspectivesPeer-reviewed·Aug 26, 2022
- Differentiating Agonists and Competitive Antagonists of the Serotonin Type 3A (5-HT3A) Receptor
Anthony J. Davolio, Wojciech J. Jankowski, … P.‐L. Chau·bioRxiv·May 15, 2023
- Antagonist binding actively disrupts interleukin-1 receptor dynamics to block co-receptor recruitment
Chandran Nithin, Ayomide Fasemire, Sebastian Kmiecik·Computational and Structural Biotechnology JournalPeer-reviewed·Mar 1, 2026
- Towards comprehensive allosteric control over protein activity
E. Guarnera, I. N. Berezovsky·bioRxiv·Aug 4, 2018
- Decoding Angiotensin II Type 1 Receptor Allosteric Communication to Gq and β-arrestin
A. K. Nivedha, Y. Cao, … N. Vaidehi·bioRxiv·May 17, 2021
- Prioritizing Neuroactive Ligands Using Motif-Guided Virtual Discovery and Zebrafish Profiling
Ari Benjamin Ginsparg, Jaqueline A. Martinez, … Summer B. Thyme·npj Drug Discovery.Peer-reviewed·Jul 21, 2026